|
|
||||||||||||||
|
|
|||||||||||||||
Leader |
1 Division of Medical Genetics, Adrian Building, University of Leicester, Leicester LE1 7RH, UK
Dr Thomson jrt10{at}leicester.ac.uk Primary pulmonary hypertension (PPH) represents the end stage of a disruption of pulmonary vascular integrity, of unknown cause. Although PPH is associated with several systemic disorders, there have hitherto been few clues as to the aetiological factors responsible for the pathogenesis of this condition. As an example of the application of modern molecular genetics and positional cloning, this leader desribes the range of studies currently under way, which aim to find the gene that underlies PPH, and summarises the implications of the identification of such a gene.
Key Words: pulmonary hypertension genetics chromosome 2q33
This article has been cited by other articles:
![]() |
M. T. Nasim, A. Ghouri, B. Patel, V. James, N. Rudarakanchana, N. W. Morrell, and R. C. Trembath Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension Hum. Mol. Genet., June 1, 2008; 17(11): 1683 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Machado, R. Koehler, E. Glissmeyer, C. Veal, J. Suntharalingam, M. Kim, J. Carlquist, M. Town, C. G. Elliott, M. Hoeper, et al. Genetic Association of the Serotonin Transporter in Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 793 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology Eur. Heart J., December 2, 2004; 25(24): 2243 - 2278. [Full Text] [PDF] |
||||
![]() |
P J Van Diest, H Holzel, D Burnett, and J Crocker Impactitis: new cures for an old disease J. Clin. Pathol., November 1, 2001; 54(11): 817 - 819. [Full Text] [PDF] |
||||
![]() |
R. C. Trembath, J. R. Thomson, R. D. Machado, N. V. Morgan, C. Atkinson, I. Winship, G. Simonneau, N. Galie, J. E. Loyd, M. Humbert, et al. Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia N. Engl. J. Med., August 2, 2001; 345(5): 325 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Galiè and A. Torbicki GENERAL CARDIOLOGY: Pulmonary arterial hypertension: new ideas and perspectives Heart, April 1, 2001; 85(4): 475 - 480. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |